As of 2024-12-12, the Intrinsic Value of Genoway SA (ALGEN.PA) is
9.60 EUR. This ALGEN.PA valuation is based on the model Discounted Cash Flows (Growth Exit 10Y).
With the current market price of 3.97 EUR, the upside of Genoway SA is
141.70%.
The range of the Intrinsic Value is 4.77 - 85.97 EUR
ALGEN.PA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(7.76) - (0.94) |
(1.34) |
-133.8% |
| DCF (Growth 10y) |
4.77 - 85.97 |
9.60 |
141.7% |
| DCF (EBITDA 5y) |
6.06 - 9.43 |
7.78 |
95.9% |
| DCF (EBITDA 10y) |
8.44 - 13.90 |
11.10 |
179.5% |
| Fair Value |
3.51 - 3.51 |
3.51 |
-11.62% |
| P/E |
2.84 - 3.96 |
3.61 |
-9.2% |
| EV/EBITDA |
4.87 - 9.56 |
6.25 |
57.5% |
| EPV |
0.53 - 0.80 |
0.66 |
-83.3% |
| DDM - Stable |
2.12 - 29.29 |
15.70 |
295.6% |
| DDM - Multi |
6.00 - 65.37 |
11.07 |
178.8% |
ALGEN.PA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
35.53 |
| Beta |
0.89 |
| Outstanding shares (mil) |
8.95 |
| Enterprise Value (mil) |
37.04 |
| Market risk premium |
5.82% |
| Cost of Equity |
6.41% |
| Cost of Debt |
5.00% |
| WACC |
5.98% |